Have a personal or library account? Click to login
Linking Gut Microbiota and Irritable Bowel Syndrome (Ibs): A Review Cover

Linking Gut Microbiota and Irritable Bowel Syndrome (Ibs): A Review

Open Access
|Sep 2025

References

  1. <bold>Aggeletopoulou I, Triantos C</bold>. Microbiome shifts and their impact on gut physiology in irritable bowel syndrome. Int J Mol Sci., 2024 Nov; 25(22):12395 <a href="https://doi.org/10.3390/ijms252212395" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3390/ijms252212395</a>
  2. <bold>Almonajjed MB, Wardeh M, Atlagh A, Ismaiel A, Popa SL, Rusu F, Dumitrascu DL</bold>. Impact of Microbiota on Irritable Bowel Syndrome Pathogenesis and Management: A Narrative Review. Medicina (Kaunas), 2025 Jan; 61:109 <a href="https://doi.org/10.3390/medicina61010109" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3390/medicina61010109</a>
  3. <bold>Ankersen DV, Weimers P</bold>. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial. J. Med. Internet Res., 2021 Dec; 23:e30291 <a href="https://doi.org/10.2196/30291" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.2196/30291</a>
  4. <bold>Baj A, Moro E, Bistoletti M, Orlandi V, Crema F, Giaroni C</bold>. Gluta-matergic signaling along the microbiota-gut-brain axis. Int J Mol Sci., 2019 Mar; 20:1482 <a href="https://doi.org/10.3390/ijms20061482" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3390/ijms20061482</a>
  5. <bold>Brenner DM, Ladewski AM, Kinsinger SW</bold>. Development and Current State of Digital Therapeutics for Irritable Bowel Syndrome. Clin Gastroenterol Hepatol., 2024 Feb; 22:222-234 https://doi. org/<a href="https://doi.org/10.1016/j.cgh.2023.09.013" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.cgh.2023.09.013</a>
  6. <bold>Cammarota G, Ianiro G, et al</bold>. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut., 2019 Dec; 68:2111-2121 <a href="https://doi.org/10.1136/gutjnl-2019-319548" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1136/gutjnl-2019-319548</a>
  7. <bold>Campaniello D, Bevilacqua A, Speranza B, Racioppo A, Sinigaglia M, Corbo MR</bold>. A narrative review on the use of probiotics in several diseases. Evidence and perspectives. Front Nutr., 2023 Jul; 10:10:1209238 <a href="https://doi.org/10.3389/fnut.2023.1209238" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3389/fnut.2023.1209238</a>
  8. <bold>Canavan C, West J, Card T</bold>. The epidemiology of irritable bowel syndrome. Clin Epidemiol., 2014 Feb; 4:71-80 <a href="https://doi.org/10.2147/CLEP.S40245" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.2147/CLEP.S40245</a>
  9. <bold>Cheng X, Ren C, Mei X, Jiang Y, Zhou Y</bold>. Gut microbiota and irritable bowel syndrome: status and prospect. Front. Med., 2024 Oct; 11:1429133 <a href="https://doi.org/10.3389/fmed.2024.1429133" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3389/fmed.2024.1429133</a>
  10. <bold>Chey WD, Keefer L, Whelan K, Gibson PR</bold>. Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome. Gastroenterology. 2021 Jan; 160:47-62 <a href="https://doi.org/10.1053/j.gastro.2020.06.099" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1053/j.gastro.2020.06.099</a>
  11. <bold>Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC</bold>. The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy. Front Microbiol., 2019 Jun; 10:1136. Erratum in: Front Microbiol., 10: 1870 <a href="https://doi.org/10.3389/fmicb.2019.01136" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3389/fmicb.2019.01136</a>
  12. <bold>D’Antongiovanni V, Pellegrini C, Fornai M, Colucci R, Blandizzi C, Antonioli L, Bernardini N</bold>. Intestinal epithelial barrier and neuromuscular compartment in health and disease. World J Gastroenterol., 2020 Apr; 26:1564-1579 <a href="https://doi.org/10.3748/wjg.v26." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3748/wjg.v26.</a> i14.1564
  13. <bold>Edogawa S &amp; Grover M, et al</bold>. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS. Gut., 2020 Jan; 69:62-73 <a href="https://doi.org/10.1136/gutjnl-2018-317416" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1136/gutjnl-2018-317416</a>
  14. <bold>Ek WE Reznichenko A, et al</bold>. Exploring the genetics of irritable bowel syndrome: A GWA study in the general population and replication in multinational case-control cohorts. Gut, 2015 Nov; 64:1774–1782 <a href="https://doi.org/10.1136/gutjnl-2014-307997" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1136/gutjnl-2014-307997</a>
  15. <bold>El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T</bold>. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut., 2020 May; 69:859-867 <a href="https://doi.org/10.1136/gutjnl-2019-319630" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1136/gutjnl-2019-319630</a>
  16. <bold>Fukui H, Nishida A</bold>. Usefulness of Machine Learning-Based Gut Microbiome Analysis for Identifying Patients with Irritable Bowels Syndrome. J. Clin. Med., 2020 Jul; 9:2403 <a href="https://doi.org/10.3390/jcm9082403" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3390/jcm9082403</a>
  17. <bold>Fuochi V, Furneri PM</bold>. Applications of Probiotics and Their Potential Health Benefits. International Journal of Molecular Sciences., 2023 Nov; 24:15915 <a href="https://doi.org/10.3390/ijms242115915" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3390/ijms242115915</a>
  18. <bold>Halkjær SI, Christensen AH, Lo BZS, Browne PD, Günther S, Hansen LH, Petersen AM</bold>. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut., 2018 Dec; 67(12):2107-2115 <a href="https://doi.org/10.1136/gutjnl-2018-316434" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1136/gutjnl-2018-316434</a>
  19. <bold>Halkjær SI, Lo B, et al</bold>. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. World J Gastroenterol., 2023 May 28; 29(20):3185- 3202. <a href="https://doi.org/10.3748/wjg.v29.i20.3185" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3748/wjg.v29.i20.3185</a>
  20. <bold>Hammerle CW, Surawicz CM</bold>. Updates on treatment of irritable bowel syndrome. World J Gastroenterol., 2008 May 7;14(17):2639- 49 <a href="https://doi.org/10.3748/wjg.14.2639" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3748/wjg.14.2639</a>
  21. <bold>Holvoet T, De Looze D et al</bold>. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial. Gastroenterology., 2021 Jan; 160(1):145-157.e8 <a href="https://doi.org/10.1053/j." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1053/j.</a> gastro.2020.07.013
  22. <bold>Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V</bold>. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther., 2005 Jun; 21(11):1365- 75 <a href="https://doi.org/10.1111/j.1365-2036.2005.02463.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1111/j.1365-2036.2005.02463.x</a>
  23. <bold>Jacobs JP &amp; Lagishetty V et al</bold>. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes. Microbiome, 2023 Jan 10; 11(1):5 <a href="https://doi.org/10.1186/s40168-022-01450-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1186/s40168-022-01450-5</a>
  24. <bold>Johnsen PH, Hilpüsch F, Cavanagh JP, Leikanger IS, Kolstad C, Valle PC, Goll R</bold>. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol., 2018 Jan; 3(1):17-24 <a href="https://doi.org/10.1016/S2468-1253(17)30338-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/S2468-1253(17)30338-2</a>
  25. <bold>Lacy BE, Weiser K, De Lee R</bold>. The treatment of irritable bowel syndrome. Therap Adv Gastroenterol., 2009 Jul; 2(4):221-38 <a href="https://doi.org/10.1177/1756283X09104794" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1177/1756283X09104794</a>
  26. <bold>Li X, Li X, Xiao H, Xu J, He J, Xiao C, Zhang B, Cao M, Hong W</bold>. Meta-analysis of gut microbiota alterations in patients with irritable bowel syndrome. Front. Microbio., 2024 Dec 24; 15:1492349. <a href="https://doi.org/10.3389/fmicb.2024.1492349" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3389/fmicb.2024.1492349</a>
  27. <bold>Li ZY, Zhang N, Wen S, Zhang J, Sun XL, Fan XM, Sun YH</bold>. Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome. Clin Res Hepatol Gastroenterol, 2017 Sep; 41(4):459-465. <a href="https://doi.org/10.1016/j.clinre.2016.12.007" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.clinre.2016.12.007</a>
  28. <bold>Lovell RM &amp; Ford AC</bold>. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol., 2012 Jul; 10(7):712-721.e4. <a href="https://doi.org/10.1016/j." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.</a> cgh.2012.02.029
  29. <bold>Luzzi A, Briata IM, Di Napoli I, Giugliano S, Di Sabatino A, Rescig-no M, Cena H</bold>. Prebiotics, probiotics, synbiotics and postbiotics to adolescents in metabolic syndrome. Clin Nutr., 2024 Jun; 43(6):1433-1446. <a href="https://doi.org/10.1016/j.clnu.2024.04.032" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.clnu.2024.04.032</a>
  30. <bold>Maftei NM, Raileanu CR, Balta AA, Ambrose L, Boev M, Marin DB, Lisa EL</bold>. The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties. Microorganisms., 2024 Jan 23; 12(2):234. <a href="https://doi.org/10.3390/microorganisms12020234" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3390/microorganisms12020234</a>
  31. <bold>Mamieva Z, Poluektova E, Svistushkin V, Sobolev V, Shifrin O, Guarner F, Ivashkin V</bold>. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations? World J Gastroenterol., 2022 Mar 28; 28(12):1204-1219. <a href="https://doi.org/10.3748/wjg.v28." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3748/wjg.v28.</a> i12.1204
  32. <bold>Mars RAT &amp; Yang Y et al</bold>. Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome. Cell, 2020 Sep 17; 182(6):1460-1473.e17. <a href="https://doi.org/10.1016/j." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.</a> cell.2020.08.007
  33. <bold>Martyniak A, Medyńska-Przęczek A, Wędrychowicz A, Skoczeń S, Tomasik PJ</bold>. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD. Biomolecules, 2021 Dec 18; 11(12):1903. <a href="https://doi.org/10.3390/biom11121903" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3390/biom11121903</a>
  34. <bold>Menees S, Chey W</bold>. The gut microbiome and irritable bowel syndrome. F1000Res., 2018 Jul; 9:7:F1000 Faculty Rev-1029. <a href="https://doi.org/10.12688/f1000research.14592.1" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.12688/f1000research.14592.1</a>
  35. <bold>Meydan C. &amp; Afshinnekoo E. et al</bold>. Improved gastrointestinal health for irritable bowel syndrome with metagenome-guided interventions. Precis. Clin. Med., 2020 Jun; 3(2):136-146. <a href="https://doi.org/10.1093/pcmedi/pbaa013" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1093/pcmedi/pbaa013</a>
  36. <bold>Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A</bold>. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol., 2018 Feb; 11(1):1-10. <a href="https://doi.org/10.1007/s12328-017-0813-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s12328-017-0813-5</a>
  37. <bold>Oka P, Parr H, Barberio B., Black C.J., Savarino E.V., Ford A.C</bold>. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. The Lancet Gastroenterology &amp; Hepatology, 2020 Oct; 5(10):908-917. <a href="https://doi.org/10.1016/S2468-1253(20)30217-X" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/S2468-1253(20)30217-X</a>
  38. <bold>Palsson OS &amp; Yang Y. et al</bold>. Development and Validation of the Rome IV Diagnostic Questionnaire for Adults. Gastroenterology, 2016 Feb; 13:S0016-5085(16)00180-3. <a href="https://doi.org/10.1053/j.gastro.2016.02.014" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1053/j.gastro.2016.02.014</a>
  39. <bold>Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P</bold>. Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. Gastroenterology, 2019 Jul; 157(1):97- 108. <a href="https://doi.org/10.1053/j.gastro.2019.03.049" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1053/j.gastro.2019.03.049</a>
  40. <bold>Qiao X, Zhang H, Shan L</bold>. Probiotic interventions and quality of life in patients with gastrointestinal diseases: A comprehensive review. Adv Clin Exp Med., 2025 Apr; 34(4):641-658. <a href="https://doi.org/10.17219/acem/188108" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.17219/acem/188108</a>
  41. <bold>Ranjha M, MAN, Shafique B, Batool M, Kowalczewski PŁ, Shehzad Q, Usman M, Manzoor MF, Zahra SM, Yaqub S, Aadil RM</bold>. Nutritional and Health Potential of Probiotics: A Review. Applied Sciences, 2021; 11(23),11204. <a href="https://doi.org/10.3390/app112311204" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3390/app112311204</a>
  42. <bold>Rijkers GT, de Vos WM, Brummer RJ, Morelli L, Corthier G, Marteau P</bold>. Health benefits and health claims of probiotics: bridging science and marketing. British Journal of Nutrition., 2011 Nov; 106(9):1291-6. <a href="https://doi.org/10.1017/S000711451100287X" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1017/S000711451100287X</a>
  43. <bold>Ruiz-Sánchez C, Escudero-López B, Fernández-Pachón MS</bold>. Evaluation of the efficacy of probiotics as treatment in irritable bowel syndrome. Endocrinol. Diabetes Nutr., 2024 Jan; 71(1):19-30. <a href="https://doi.org/10.1016/j.endien.2024.01.003" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.endien.2024.01.003</a>
  44. <bold>Sainsbury A, Ford AC</bold>. Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents. Therap Adv Gastroenterol., 2011 Mar; 4(2):115-27. <a href="https://doi.org/10.1177/1756283X10387203" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1177/1756283X10387203</a>
  45. <bold>Shaikh SD, Sun N, Canakis A, Park WY, Weber HC</bold>. Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review. J Clin Med. 2023 Mar 28; 12(7):2558. <a href="https://doi.org/10.3390/jcm12072558" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3390/jcm12072558</a>
  46. <bold>Shrestha B, Patel D, Shah H, Hanna KS, Kaur H, Alazzeh MS, Thandavaram A, Channar A., Purohit A., Venugopal S</bold>. The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review. Cureus, 2022 Aug 16; 14(8):e28064. <a href="https://doi.org/10.7759/cureus.28064" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.7759/cureus.28064</a>
  47. <bold>Sperber AD, Bangdiwala SI, et al</bold>. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology, 2021 Jan; 160(1):99- 114.e3. <a href="https://doi.org/10.1053/j.gastro.2020.04.014" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1053/j.gastro.2020.04.014</a>
  48. <bold>Surdea-Blaga T, Ciobanu L, Ismaiel A, Dumitrascu DL</bold>. Microbiome in irritable bowel syndrome: advances in the field – A scoping review. Microb Health Dis, 2024 Aug; 6:e1017. <a href="https://doi.org/10.26355/mhd_20248_1017." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.26355/mhd_20248_1017.</a>
  49. <bold>Staudacher HM, Black CJ, Teasdale SB, Mikocka-Walus A, Keefer L</bold>. Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management. Nat Rev Gastroenterol Hepatol. 2023 Sep; 20(9):582-596. <a href="https://doi.org/10.1038/s41575-" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1038/s41575-</a> 023-00794-z
  50. <bold>Talley NJ</bold>. Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol., 2003 Oct; 56(4):362-9. <a href="https://doi.org/10.1046/j.1365-2125.2003.01966.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1046/j.1365-2125.2003.01966.x</a>
  51. <bold>Umeano L, Iftikhar S, Alhaddad SF, Paulsingh CN, Riaz MF, Garg G, Mohammed L</bold>. Effectiveness of probiotic use in alleviating symptoms of irritable bowel syndrome: A systematic review. Cureus, 2024 Apr 15; 16(4):e58306. <a href="https://doi.org/10.7759/cureus.58306" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.7759/cureus.58306</a>
  52. <bold>Wall GC, Bryant GA, Bottenberg MM, Maki ED, Miesner AR</bold>. Irritable bowel syndrome: a concise review of current treatment concepts. World J Gastroenterol., 2014 Jul 21; 20(27):8796-806. <a href="https://doi.org/10.3748/wjg.v20.i27.8796" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3748/wjg.v20.i27.8796</a>
  53. <bold>Zeichner D</bold>. Coping with IBS from the Inside Out: Relaxation Techniques to Manage Symptoms. San Diego, CA (USA): The International Foundation for Gastrointestinal Disorders; 2005. https://iffgd.org/resources/publication-library/coping-with-ibs-from-the-inside-out-relaxation-techniques-to-manage-symptoms/
DOI: https://doi.org/10.2478/am-2025-0012 | Journal eISSN: 2545-3149 | Journal ISSN: 0079-4252
Language: English, Polish
Page range: 147 - 159
Submitted on: Apr 14, 2025
Accepted on: Aug 25, 2025
Published on: Sep 30, 2025
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2025 Michał Karasek, Michał Szyszko, Krzysztof Polański, Sylwia Andrzejczuk, Martyna Kasela, Urszula Kosikowska, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.